338 related articles for article (PubMed ID: 30030293)
1. Bacteria-free minicircle DNA system to generate integration-free CAR-T cells.
Cheng C; Tang N; Li J; Cao S; Zhang T; Wei X; Wang H
J Med Genet; 2019 Jan; 56(1):10-17. PubMed ID: 30030293
[TBL] [Abstract][Full Text] [Related]
2. Generation of Chimeric Antigen Receptor T Cells Using Gammaretroviral Vectors.
Mo F; Mamonkin M
Methods Mol Biol; 2020; 2086():119-130. PubMed ID: 31707671
[TBL] [Abstract][Full Text] [Related]
3. Minicircle-Based Engineering of Chimeric Antigen Receptor (CAR) T Cells.
Hudecek M; Gogishvili T; Monjezi R; Wegner J; Shankar R; Kruesemann C; Miskey C; Ivics Z; Schmeer M; Schleef M
Recent Results Cancer Res; 2016; 209():37-50. PubMed ID: 28101686
[TBL] [Abstract][Full Text] [Related]
4. Optimized Production of Lentiviral Vectors for CAR-T Cell.
Moço PD; de Abreu Neto MS; Fantacini DMC; Picanço-Castro V
Methods Mol Biol; 2020; 2086():69-76. PubMed ID: 31707668
[TBL] [Abstract][Full Text] [Related]
5. CAR T Cells Generated Using Sleeping Beauty Transposon Vectors and Expanded with an EBV-Transformed Lymphoblastoid Cell Line Display Antitumor Activity In Vitro and In Vivo.
Chicaybam L; Abdo L; Carneiro M; Peixoto B; Viegas M; de Sousa P; Fornazin MC; Spago MC; Albertoni Laranjeira AB; de Campos-Lima PO; Nowill A; Barros LRC; Bonamino MH
Hum Gene Ther; 2019 Apr; 30(4):511-522. PubMed ID: 30793967
[TBL] [Abstract][Full Text] [Related]
6. Comparative analysis and optimization of protocols for producing recombinant lentivirus carrying the anti-Her2 chimeric antigen receptor gene.
Yuan W; Chen J; Cao Y; Yang L; Shen L; Bian Q; Bin S; Li P; Cao J; Fang H; Gu H; Li H
J Gene Med; 2018 Jul; 20(7-8):e3027. PubMed ID: 29851200
[TBL] [Abstract][Full Text] [Related]
7. Enhanced CAR T-cell engineering using non-viral Sleeping Beauty transposition from minicircle vectors.
Monjezi R; Miskey C; Gogishvili T; Schleef M; Schmeer M; Einsele H; Ivics Z; Hudecek M
Leukemia; 2017 Jan; 31(1):186-194. PubMed ID: 27491640
[TBL] [Abstract][Full Text] [Related]
8. Safe engineering of CAR T cells for adoptive cell therapy of cancer using long-term episomal gene transfer.
Jin C; Fotaki G; Ramachandran M; Nilsson B; Essand M; Yu D
EMBO Mol Med; 2016 Jul; 8(7):702-11. PubMed ID: 27189167
[TBL] [Abstract][Full Text] [Related]
9. AAVS1 site-specific integration of the CAR gene into human primary T cells using a linear closed-ended AAV-based DNA vector.
Chen W; Tan L; Zhou Q; Li W; Li T; Zhang C; Wu J
J Gene Med; 2020 Apr; 22(4):e3157. PubMed ID: 31901177
[TBL] [Abstract][Full Text] [Related]
10. Generation of CAR-T Cells with Sleeping Beauty Transposon Gene Transfer.
Prommersberger S; Monjezi R; Botezatu L; Miskey C; Amberger M; Mestermann K; Hudecek M; Ivics Z
Methods Mol Biol; 2022; 2521():41-66. PubMed ID: 35732992
[TBL] [Abstract][Full Text] [Related]
11. Preclinical Evaluation of Chimeric Antigen Receptor-Modified T Cells Specific to Epithelial Cell Adhesion Molecule for Treating Colorectal Cancer.
Zhang BL; Li D; Gong YL; Huang Y; Qin DY; Jiang L; Liang X; Yang X; Gou HF; Wang YS; Wei YQ; Wang W
Hum Gene Ther; 2019 Apr; 30(4):402-412. PubMed ID: 30693795
[TBL] [Abstract][Full Text] [Related]
12. Reversible Transgene Expression Reduces Fratricide and Permits 4-1BB Costimulation of CAR T Cells Directed to T-cell Malignancies.
Mamonkin M; Mukherjee M; Srinivasan M; Sharma S; Gomes-Silva D; Mo F; Krenciute G; Orange JS; Brenner MK
Cancer Immunol Res; 2018 Jan; 6(1):47-58. PubMed ID: 29079655
[TBL] [Abstract][Full Text] [Related]
13. Generation of CAR-T cells using lentiviral vectors.
Poorebrahim M; Quiros-Fernandez I; Fakhr E; Cid-Arregui A
Methods Cell Biol; 2022; 167():39-69. PubMed ID: 35152998
[TBL] [Abstract][Full Text] [Related]
14. Expanding CAR T cells in human platelet lysate renders T cells with in vivo longevity.
Torres Chavez A; McKenna MK; Canestrari E; Dann CT; Ramos CA; Lulla P; Leen AM; Vera JF; Watanabe N
J Immunother Cancer; 2019 Nov; 7(1):330. PubMed ID: 31779709
[TBL] [Abstract][Full Text] [Related]
15. Next generation chimeric antigen receptor T cells: safety strategies to overcome toxicity.
Yu S; Yi M; Qin S; Wu K
Mol Cancer; 2019 Aug; 18(1):125. PubMed ID: 31429760
[TBL] [Abstract][Full Text] [Related]
16. High-Affinity GD2-Specific CAR T Cells Induce Fatal Encephalitis in a Preclinical Neuroblastoma Model.
Richman SA; Nunez-Cruz S; Moghimi B; Li LZ; Gershenson ZT; Mourelatos Z; Barrett DM; Grupp SA; Milone MC
Cancer Immunol Res; 2018 Jan; 6(1):36-46. PubMed ID: 29180536
[TBL] [Abstract][Full Text] [Related]
17. Preclinical Assessment of Suitable Natural Killer Cell Sources for Chimeric Antigen Receptor Natural Killer-Based "Off-the-Shelf" Acute Myeloid Leukemia Immunotherapies.
Kloess S; Oberschmidt O; Dahlke J; Vu XK; Neudoerfl C; Kloos A; Gardlowski T; Matthies N; Heuser M; Meyer J; Sauer M; Falk C; Koehl U; Schambach A; Morgan MA
Hum Gene Ther; 2019 Apr; 30(4):381-401. PubMed ID: 30734584
[TBL] [Abstract][Full Text] [Related]
18. Chimeric Antigen Receptor T Cells: Extending Translation from Liquid to Solid Tumors.
Morgan MA; Schambach A
Hum Gene Ther; 2018 Oct; 29(10):1083-1097. PubMed ID: 30156435
[TBL] [Abstract][Full Text] [Related]
19. Generation of CAR T-cells using γ-retroviral vector.
Watanabe N; McKenna MK
Methods Cell Biol; 2022; 167():171-183. PubMed ID: 35152995
[TBL] [Abstract][Full Text] [Related]
20. A new approach to CAR T-cell gene engineering and cultivation using piggyBac transposon in the presence of IL-4, IL-7 and IL-21.
Ptáčková P; Musil J; Štach M; Lesný P; Němečková Š; Král V; Fábry M; Otáhal P
Cytotherapy; 2018 Apr; 20(4):507-520. PubMed ID: 29475789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
